Suma Krishnan
President at Krystal Biotech, Inc. (KRYS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $34.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5201,326,625 held (−0%) | $354.54 | $184K | -6.5% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,0061,324,619 held (−0%) | $355.57 | $713K | -6.7% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,2671,321,352 held (−0%) | $356.37 | $1.2M | -6.9% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,9621,317,390 held (−0%) | $357.57 | $1.4M | -7.3% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,1801,314,210 held (−0%) | $358.42 | $1.1M | -7.5% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,3921,310,818 held (−0%) | $359.39 | $1.2M | -7.7% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,3201,308,498 held (−0%) | $360.47 | $836K | -8.0% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,2421,307,256 held (−0%) | $361.61 | $449K | -8.3% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,9921,305,264 held (−0%) | $362.65 | $722K | -8.6% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5651,304,699 held (−0%) | $363.34 | $205K | -8.7% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,3291,303,370 held (−0%) | $364.48 | $484K | -9.0% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 8261,302,544 held (−0%) | $365.41 | $302K | -9.2% |
| Sep 4SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3991,302,145 held (−0%) | $366.56 | $146K | -9.5% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3201,402,835 held (−0%) | $300.75 | $96K | +10.3% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5931,402,242 held (−0%) | $302.25 | $179K | +9.7% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2471,401,995 held (−0%) | $303.17 | $75K | +9.4% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4001,401,595 held (−0%) | $304.89 | $122K | +8.8% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4801,401,115 held (−0%) | $305.87 | $147K | +8.4% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,3481,399,767 held (−0%) | $307.09 | $414K | +8.0% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 12,7291,387,038 held (−1%) | $307.81 | $3.9M | +7.7% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,8031,383,235 held (−0%) | $308.89 | $1.2M | +7.4% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,8011,380,434 held (−0%) | $309.95 | $868K | +7.0% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,0391,378,395 held (−0%) | $310.94 | $634K | +6.6% |
| Jun 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2401,378,155 held (−0%) | $311.65 | $75K | +6.4% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4071,427,748 held (−0%) | $257.32 | $105K | +28.9% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5891,427,159 held (−0%) | $258.54 | $152K | +28.3% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 6681,426,491 held (−0%) | $259.61 | $173K | +27.7% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,6671,422,824 held (−0%) | $260.37 | $955K | +27.4% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,9311,419,893 held (−0%) | $261.41 | $766K | +26.9% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,9381,417,955 held (−0%) | $262.35 | $508K | +26.4% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,2481,415,707 held (−0%) | $263.58 | $593K | +25.8% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 4,8521,410,855 held (−0%) | $264.64 | $1.3M | +25.3% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 6,0001,404,855 held (−0%) | $265.16 | $1.6M | +25.1% |
| Mar 6SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,7001,403,155 held (−0%) | $266.42 | $453K | +24.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 7001,438,011 held (−0%) | $214.25 | $150K | +54.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 6001,437,411 held (−0%) | $215.49 | $129K | +53.9% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,4001,436,011 held (−0%) | $216.97 | $304K | +52.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3,5931,432,418 held (−0%) | $218.83 | $786K | +51.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5,4191,426,999 held (−0%) | $219.68 | $1.2M | +51.0% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,6271,424,372 held (−0%) | $220.52 | $579K | +50.4% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 10,4611,413,911 held (−1%) | $221.82 | $2.3M | +49.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2001,413,711 held (−0%) | $222.38 | $44K | +49.1% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 9561,507,100 held (−0%) | $214.28 | $205K | +54.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 3441,506,756 held (−0%) | $215.48 | $74K | +53.9% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 1,6001,505,156 held (−0%) | $217.04 | $347K | +52.8% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,5771,502,579 held (−0%) | $218.72 | $564K | +51.6% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 5,6931,496,886 held (−0%) | $219.53 | $1.2M | +51.1% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 2,6251,494,261 held (−0%) | $220.34 | $578K | +50.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 10,5051,483,756 held (−1%) | $221.78 | $2.3M | +49.5% |
| Dec 5SEC | KRYSKrystal Biotech, Inc. | Sell Plan | 7001,483,056 held (−0%) | $222.20 | $156K | +49.2% |
- Sell
President Suma Krishnan sold $184K of KRYS at $354.54 — pre-scheduled 10b5-1 plan sale.
- Sell
President Suma Krishnan sold $713K of KRYS at $355.57 — pre-scheduled 10b5-1 plan sale.
- Sell
President Suma Krishnan sold $1.2M of KRYS at $356.37 — pre-scheduled 10b5-1 plan sale.
- Sell
President Suma Krishnan sold $1.4M of KRYS at $357.57 — pre-scheduled 10b5-1 plan sale.
- Sell
President Suma Krishnan sold $1.1M of KRYS at $358.42 — pre-scheduled 10b5-1 plan sale.
- Sell
President Suma Krishnan sold $1.2M of KRYS at $359.39 — pre-scheduled 10b5-1 plan sale.